Guo Taipin, Zhu Bowen, Zhang Qian, Yang Yejiao, He Qi, Zhang Xinghe, Tai Xiantao
School of Acupuncture-Tuina and Rehabilitation, Yunnan University of Traditional Chinese Medicine, Kunming, China.
JMIR Res Protoc. 2017 Jan 5;6(1):e2. doi: 10.2196/resprot.5944.
Cerebral palsy (CP), a childhood disease of high morbidity and serious harmfulness, has no effective therapies to completely relieve the associated pain. Acupuncture has been used widely in China to alleviate several CP symptoms, such as pain and motion disorders, despite the deficiency of high-quality evidence related to this practice.
The aim of this systematic review protocol is to assess the efficacy and safety of acupuncture for the treatment of children with CP.
The following electronic databases will be searched: Cochrane Library, Web of Science, EBASE, Springer, World Health Organization International Clinical Trials Registry Platform, China National Knowledge Infrastructure, Wan-fang database, Chinese Biomedical Literature Database, Chinese Scientific Journal Database, and other sources. All published randomized controlled trials from inception to December 2016 will be included. RevMan V.5.3 software will be implemented for the assessment of bias risk, data synthesis, subgroup analysis, and meta-analyses if inclusion conditions are met. Individuals recruited into the trials will include children with all types of CP, and these individuals will be involved as coresearchers to develop and evaluate the efficacy and safety of acupuncture for the treatment of children with CP. Due to language barriers, only English and Chinese articles will be retrieved.
The systematic review will synthesize the available knowledge surrounding acupuncture for children with CP. The findings will be synthesized to determine the efficacy and safety of acupuncture for children with CP.
The review has not been completed. This protocol presents a proper method to implement the systematic review, and ensures transparency for the completed review. Findings from the systematic review will be disseminated in a peer-reviewed journal and results will be presented at relevant conferences. The data of individual patients will not be included, so ethical approval is not required.
PROSPERO registration number: CRD42016038275, http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016038275 (Archived by WebCite at http://www.webcitation/6nGxoJrqm.
脑瘫(CP)是一种发病率高且危害严重的儿童疾病,目前尚无有效疗法能完全缓解其相关疼痛。尽管缺乏高质量证据,但针灸在中国已被广泛用于缓解脑瘫的多种症状,如疼痛和运动障碍。
本系统评价方案旨在评估针灸治疗脑瘫患儿的疗效和安全性。
将检索以下电子数据库:考克兰图书馆、科学引文索引数据库、荷兰医学文摘数据库、施普林格数据库、世界卫生组织国际临床试验注册平台、中国知网、万方数据库、中国生物医学文献数据库、维普数据库及其他来源。纳入所有自数据库建库至2016年12月发表的随机对照试验。若符合纳入条件,将采用RevMan V.5.3软件进行偏倚风险评估、数据合成、亚组分析和荟萃分析。纳入试验的受试者将包括所有类型脑瘫患儿,这些患儿将作为共同研究者参与评估针灸治疗脑瘫患儿的疗效和安全性。由于语言障碍,仅检索英文和中文文章。
本系统评价将综合现有关于针灸治疗脑瘫患儿的知识。将综合研究结果以确定针灸治疗脑瘫患儿的疗效和安全性。
本评价尚未完成。本方案提供了实施系统评价的恰当方法,并确保了完成评价过程的透明度。系统评价结果将在同行评审期刊上发表,并在相关会议上汇报。因不纳入个体患者数据,故无需伦理批准。
国际前瞻性系统评价注册库(PROSPERO)注册号:CRD42016038275,http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016038275(由WebCite存档于http://www.webcitation/6nGxoJrqm)